Search

​On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...

The much-anticipated Stakeholders’ call took place on April 25th. As expected, there was not a lot of detailed direction provided although it was acknowledged that to the extent questions were not answered USCIS would try to otherwise address the questions at a later point in time. The following...

Saul Ewing is proud to sponsor the 2023 ABA Litigation Section Annual Conference coming up on April 19-21, 2023 at the Loews Atlanta Hotel in Atlanta, Georgia. Litigation Department Chair Cathleen Devlin will be a panelist on a CLE program titled “ESG, It’s Easy as 1-2-3?,” taking place on Thursday...

THE IMPACT ESG HAS ON C&D DECISION MAKING Partner Sean O'Neill will join a panel to discuss how ESG is being integrated into everyday development and design decisions.